Phosphodiesterase-5 inhibitors use and risk for mortality and metastases among male patients with colorectal cancer

Phosphodiesterase-5 (PDE5) inhibitors are suggested to have anti-tumor effects and to inhibit surgery-induced immunosuppression. We aimed to explore whether post-diagnostic use of PDE5 inhibitors was associated with a better prognosis among male patients with colorectal cancer (CRC) and the role of...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Wuqing, Sundquist, Jan, Sundquist, Kristina, Ji, Jianguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314744/
https://www.ncbi.nlm.nih.gov/pubmed/32581298
http://dx.doi.org/10.1038/s41467-020-17028-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314744/
https://www.ncbi.nlm.nih.gov/pubmed/32581298
http://dx.doi.org/10.1038/s41467-020-17028-4

Ejemplares similares